RSS   Newsletter   Contact   Advertise with us

Amgen announces additional investment in BeiGene

Christian Fernsby ▼ | July 13, 2020
Amgen announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's current pro rata ownership of BeiGene at approximately 20.3%.
Amgen
Offering   Amgen


Topics: Amgen This additional investment reflects Amgen's confidence in the progress the companies are making in their ongoing oncology collaboration in China, the world's second largest pharmaceutical market.


 

MORE INSIDE POST